Troponin: A risk-defining biomarker for emergency department physicians

Cullen, Louise (2011) Troponin: A risk-defining biomarker for emergency department physicians. Emergency Medicine Australasia, 23 4: 391-394. doi:10.1111/j.1742-6723.2011.01458.x

Author Cullen, Louise
Title Troponin: A risk-defining biomarker for emergency department physicians
Journal name Emergency Medicine Australasia   Check publisher's open access policy
ISSN 1742-6723
Publication date 2011-08
Sub-type Editorial
DOI 10.1111/j.1742-6723.2011.01458.x
Volume 23
Issue 4
Start page 391
End page 394
Total pages 4
Place of publication Richmond, VIC, Australia
Publisher Wiley-Blackwell Publishing Asia
Collection year 2012
Language eng
Formatted abstract
In this issue of Emergency Medicine Australasia Jairam et al. report their findings on the clinical impact of using a new high-sensitivity troponin assay in a tertiary teaching hospital in New Zealand. Troponin testing was duplicated in patients in whom troponin (Tn) was ordered as part of their clinical management, using two assays: a 4th generation troponin T (cTnT) and the high-sensitivity TnT (hsTnT) assays. The authors aimed to identify changes in the positivity rate by using the high-sensitivity assay, and to characterize those patients in whom the hsTnT was positive, but the contemporary TnT was negative (the ‘new positive’ group). They described a significant increase in the numbers of patients with elevated troponin levels using the hsTnT assay (the ‘new positive’ group), but found that the diagnoses were often not AMI.

Few biomarkers in clinical use are as important as troponin, and yet so complex. Troponin levels continue to define patient populations, and determine the management of those patients presenting with a possible acute coronary syndrome. Recommended management guidelines for admission and monitoring practices, and the use of an invasive strategy exist for those found to be troponin positive; i.e. those with a non-ST-elevation acute myocardial infarction (NSTEMI). Improvements in the sensitivity and precision of troponin assays have occurred since the assay was first developed. This evolution has confused and challenged clinicians, and there has been limited consideration of the broad implications of this change to individual patients, the clinician and health services in general.
Keyword Acute coronary syndromes
ST-segment elevation
I assay
Practice guidelines
Unstable angina
Q-Index Code CX
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Editorial
Collection: School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 1 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 18 Sep 2011, 00:16:58 EST by System User on behalf of School of Medicine